VinnitskyV.B.. On nature of organism tolerance to tumor.Experimental Oncology (Russian)1981; 3: 3–12.
2.
VinnitskyV.B.. Role of organism in cancerogenes stages. Thesis of report. IY Vsesouzn. Conferences of Oncologists (Russian), Leningrad, 1986: 428–31.
3.
TatarinovYuS. Trophoblast-specific beta-1-glycoprotein.Advances of Modern Biology (Russian)1983; 95: 57–64.
4.
ErenpreisJ.G.. Embryonal properties of malignant cells: facts and hypotheses.Experimental Oncology (Russian)1982; 4: 13–9.
5.
VishnevskyA.S.. Tumor markers in oncogynecology.Voprosy oncologii (Russian)1984; 30: 23–34.
6.
TatarinovYuS, OlephyrenkoG.A., PetruninD.D.. Alpha-2-microglobulin.Advances of Modern Biology (Russian)1985; 100: 465–72.
7.
TsapokP.D.. Specific proteins of pregnancy.Obstetrics & Gynecology (Russian)1983; 8: 3–5.
8.
BohnH., SchimidtbergerR., ZilgH.. Isolierung des schwangerschafts-spezifischen β1-glykoproteins (SP1) und antigenverwandter proteine durch immunoadsorption.Blut1976; 32: 103–13.
9.
BohnH., WincklerW.. Isolerung und characterisierung des plazenta-proteins PP5.Arch Gynaek1977; 223: 179–86.
10.
HorneH.W., BremnerR.D.. Pregnancy proteins as tumor markers. In: SellS., ed. Cancer markers. Diagnostic and developmental significance.New York: Humana Press, 1980; 225–47.
11.
TatarinovYuS, MasyukevichV.N.. Immunochemical identification of new beta1-globulin in the blood serum of pregnant women.Bulletin Experimental Biol Med (Russian)1970; 69: 66–8.
12.
OsborneJr., RosenJ.C., NilssonB., CalvertI., BohnH.. Physicochemical studies of pregnancy-specific β1-glycoprotein: unusual ultracentrifugal and circular dichroic properties.Biochemistry1982; 21: 5523–8.
13.
RosenS.W., CalvertI., LeeN., BohnH., PapadopoulosN., OsborneJ.C.. Oligomerization of pregnancy-specific β1-glycoprotein (SP1) at physiologic pH and ionic strength.Clin Chim Acta1986; 157: 65–71.
14.
BohnH.. Systematic identification of specific oncoplacental proteins. In: FishmanW.H., ed. Oncodevelopmental markers. Biologic, diagnostic and monitoring aspects.New York: Academic Press, 1983; 69–86.
15.
LinT.M., HalbertS.P., KieferD., SpellacyW.N., GallS.. Characterization of four human pregnancy-associated plasma proteins.Am J Obstet Gynecol1974; 118: 223–36.
16.
SorensenS.. Pregnancy-“specific” β-glycoprotein (SP1): purification, characterization, quantification and clinical application in malignancies.Tumour Biology1984; 5: 275–302.
17.
TowlerC.M., GloverR.G., HorneC.H.W.. Problems encountered in the measurement of pregnancy-specific β1-glycoprotein.Clin Chim Acta1978; 87: 289–96.
18.
EngvallE., MiyashitaM., RouslahtiE.. Monoclonal antibodies in analysis of oncoplacental protein SP1 in vivo and in vitro.Cancer Res1982; 42: 2028–33.
19.
TatarinovYus, FalaleevaD.M., KalashnikovV.V.. Human pregnancy-specific bet1-globulin and its relation to chorioepithelioma.Int J Cancer1976; 17: 626–32.
20.
SeppäläM., RutanenE-M, HeikinheimoM., JalankoH., EngvallE.. Detection of trophoblastic tumor activity by pregnancy-specific beta-1-glycoprotein.Int J Cancer1978; 21: 265–7.
21.
BohnH., Biochemistry of placental proteins. In: BischofP., ed. Proteins of the placenta.Basel: S Karger, 1985; 1–25.
22.
ObiekweB., PendleburyD.J., GordonY.B., GrudzinskasJ.G., ChardT., BohnH., The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in the third trimester of normal pregnancy.Clin Chim Acta1979; 95: 509–16.
23.
SalemH.T., SeppäläM., ChardT.. The effect of thrombin on serum placental protein 5 (PP5): is PP5 the naturally occuring antithrombin II of the human placenta?Placenta1981; 2: 205–10.
24.
SiiteriJ.E., BohnH., KoistinenR., SeppäläM.. Studies on the function of placent protein 5. In: GrudzinskasJ.G., TeisnerB., SeppäläM., eds. Pregnancy proteins.Sydney: Academic Press, 1982; 263–9.
25.
GrudzinskasJ.G., MenabaweyM., WileyB.A., TeisnerB., ChardT.. The relation between the concentration of placental specific proteins in retroplacental and peripheral blood.Br J Obstet Gynaecol1979; 86: 891–3.
26.
PetruninD.D., GryasnovaI.M., PetruninaYuA, TatarinovYus. Comparative immunochemical and physico-chemical characteristics of human chorionic alpha1- and alpha2-microglobulins.Bulletin Experimental Biol and Med1978; 5: 600–2.
27.
DurkinJ.P., BrewerL.M., MacManusJ.P.. Occurance of the tumor-specific calcium-binding protein, oncomodulin, in virtually transformed normal rat kidney cells.Cancer Res1983; 43: 5390–4.
28.
MacManusJ.P.. Plasma oncomodulin is proportional to tumour burden in rats bearing Morris Hepatomas 5123 D, 5123 tc, 7288 and 7777.Tumour Biol1984; 5: 189–97.
29.
MacManusJ.P.. Occurance of a low-molecular weight-calcium-binding protein in neoplastic liver.Cancer Res1979; 39: 3000–5.
GarrettP.E., KurtzS.R.. Clinical utility of oncofetal and proteins and hormones as tumort markers.Med Clin N Amer1986; 70: 1295–307.
32.
WinikoffJ., BraunsteinG.D.. In vitro secretory patterns of human chorionic gonadotropin, placental lactogen and pregnancy-specific β1-glycoprotein.Placenta1985; 6: 417–22.
33.
RosenS.W.. Ectopic production of placental proteins and their subunits. In: BischofP., KlopperA., eds. Proteins of the placenta.Basel: S Karger, 1985; 84–101.
34.
BoslG.J., LangeP.H., FraleyE.E., GoldmanA.. Human chorionic gonadotropin and alpha-fetoprotein in the staging of non-seminomatous testicular cancer.Cancer1981; 47: 328–32.
35.
BraunsteinC.D., VaitukaitisJ.L., CarboneP.P., RossG.T.. Ectopic production of human chorionic gonadotropin by neoplasms.Ann Intern Med1973; 78: 39–45.
36.
GriffinG., VaitukaitisL.. Hormone secreting tumors. In: SellS., ed. Cancer markers.New York: Humana Press, 1980; 169–90.
37.
EinhornL.H.. Testicular cancer as a model for a curable neoplasm.Cancer Res1981; 41: 3275–80.
38.
LiC.H., DixonJ.S., ChungD.. Amino acid sequence of human chorionic somatomammotropin.Arch Biochem Biophys1973; 155: 95–110.
39.
JosimovichJ.B., MacLarenJ.A.. Presence in the human placenta and term serum of a highly lactogenic substance immunochemically related to pituitary growth hormone.Endocrinology1962; 71: 209–20.
40.
GrumbachM.M., KaplanS.L., SciarraJ.J., BurrI.M.. Chorionic growth hormone-prolactin (CGP): secretion, disposition, biological activity in man, and postulated function as the “growth hrmone” of the second half of pregnancy.Ann N Y Acad Sci1968; 148: 501–31.
41.
WeintraubB.D., RosenS.W.. Ectopic production of human chorionic somatomammotropin by non-tro-phoblastic cancers.Clin Endocrin Metab1971; 32: 94–101.
42.
ShethN.A., SurayaJ.N., ShethA.R., RanadiveK.J., Jus-sawallaD.J.. Ectopic production of human placental lactogen by human breast tumors.Cancer1977; 39: 1693–9.
43.
ZimmermanE.F., BowenD., WilsonJ.R., MadappalyM.M.. Developmental microheterogeneity of mouse α-fetoprotein: purification and characterization.Biochemistry1976; 15: 5534–43.
44.
SellS.. Alpha-Fetoprotein. In: SellS., ed. Cancer markers. Diagnostic and developmental significance. New York: Humana Press, 1980; 249–93.
45.
SmithC.J., KelleherP.C., α-Fetoprotein: separation of two molecular variants by affinity chromatography with concanavalin A-agarose.Biochem Biophys Acta1973; 317: 231–5.
46.
ThmsonD.M.P., KrupeyJ., FreedmanS.O., GoldP.. The radioimmunoassay of circulating carcinoembrionic antigen on the human digestive system.Proc Natl Acad Sci USA1969; 64: 161–7.
47.
HammarströmS., EngvallE., JohanssonB.G., SvenssonS., SundbladG., GoldsteinI.J.. Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.Proc Natl Acad Sci USA1975; 72: 1528–32.
48.
SandO., FolkersenJ., WestergaardJ.G., Sottrup-JensenL.. Characterization of human pregnancy zone protein. Compariison with human α2-macroglobulin.J Biol Chem1985; 260: 15723–35.
49.
SchwickH.G., HauptH.. Human plasma proteins of unknown function. The plasma proteins.New York: Academic Press,1984; 4: 167–219.
50.
Sottrup-JensenL., FolkersenJ., KristensenT., TackB.F.. Partial primary structure of human pregnancy zone protein: extensive sequence homology with human α2-macroglobulin.Proc Natl Acad Sci USA1984; 81: 7353–7.
51.
Van SachoultzB., StigbrandT., TarnvikA.. Inhibition of PHA-induced lymphocyte stimulation by the pregnancy zone protein.FEBS Lett1973; 38: 23–6.
52.
LundgrenE., DamberM.G., RoosG.. Cell lines with spontaneous secretion of pregnancy-associated α2-globulin.Int J Cancer1979; 24: 45–8.
53.
PorrP., AbudanO., DejicaD.. Demonstration of α2-pregnancy-associated glycoprotein (alpha2-PAG) in serum of men with different localization of cancer.Neoplasma1979; 26: 325–8.
54.
StimsonW.H., FarguharsonD.M.. Pregnancy-associated αa1- and α2-macroglobulins: two new serum proteins. In: GrudzinskasJ.G., TeisnerB., SeppäläM., eds. Pregnancy proteins.Sydney: Academic Press, 1982; 381–90.
55.
GerrieL.M., ArmstrongS.S., HorneC.H.W.. Pregnancy-associated alpha2-glycoprotein (α2-PAG): development of a sensitive enzyme-linke dimmunoassay and comparison of serum concentration in adults and children.Clin Cim Acta1986; 155: 51–60.
56.
BauerH.W., KrausH.. Variation in the level of the pregnancy-associated α2-glycoprotein in patients with gynecologic cancer.Eur J Cancer1980; 16: 1475–81.
57.
StimsonW.H.. Quantitation of a new serum α-macro-globulin in pregnant, preeclamptic and contraceptive steroid treatment subjects.IRCS Medical Sci1973; 73: 17.
58.
AndersonJ.M., GettinbyG., JhunjhunwalaS.K., BurtR.W.. Detection of mammary micrometastases by pregnancy-associated α2-glycoprotein (PAG, α2-PAG or PAM) and carcinoembrionic antigen (CEA).Europ J Cancer1979; 15: 709–14.
59.
BischofP.. Purification and characterization of pregnancy-associated plasma protein-A (PAPP-A).Arch Gynecol1979; 227: 315–26.
BischofP., AmaudruzM.. Zeil-Franck C, et al. The disappearance rate of pregnancy-associated plasma protein-A (PAPP-A) after the end of normal and abnormal pregnancies.Arch Gynecol1984; 236: 93–8.
62.
WestergaardL., SinosichM.J., GrudzinskasJ.G.. Pregnancy-associated plasma protein -A (PAPP-A) in preovulatory, non-ovulatory, healthy and atretic human ovarian follicoles during the natural cycle.Annals New York Acad Sci1985; 442: 205–11.
63.
SchindlerA.M., BordingtonP., BischofP.. Immunochemical localization of pregnancy-associated plasma protein-A in decidua and trophoblast comparison with hCG and fibrin.Placenta1984; 5: 227–36.
64.
BischofP., LauberK., WurstembergerB., GirardJ.P.. Inhibition of lymphocyte transformation by pregnancy-associated plasma protein-A (PAPP-A).J Clin Lab Immunol1982; 7: 61–5.
65.
BischofP., MeisserA., HaenggeliL.. Pregnancy-associated plasma protein -A (PAPP-A) inhibits thrombin induced coagulation of plasma.Thromb Res1983; 32: 45–55.
66.
SinosichM.J., DaveyM.W., GhoshP., GrudzinskasJ.G.. Specific inibition of human granulocyte elastase by human pregnancy-associated plasma protein-A.Biochem Int1982; 5: 777–86.
67.
SinosichM.J., DoddJ., BonifacioM.D.. Production of pregnancy-associated plasma protein -A (PAPP-A) by cultured tumour granulosa cells.Gynecol Obstet Invest1987; 23: 60–6.
InglisN.R., KirbyS., StolbachL.L., FishmanW.H.. Phenotypes of the Regan isoenzyme and identity between the placental D-variant and Nagao isoenzymes.Cancer Res1973; 33: 1657–61.
70.
GriffinM.J., PriceG.H., BassellK.L., CoxR.P., GhoshN.K.. A study of adenosine 31: 51-cyclic-monophos-phate, sodium butyrate and cortisol as inducers of HeLa alkaline phosphatase.Arch Biochem Biophys1974; 164: 619–23.
71.
LaluK., LampeloS., Vahna-PerttulaH.. Purification of three aminopeptidases from human maternal serum.Int J Biochem1985; 17: 1227–35.
72.
BehalF.J., AssersonB., DawsonF.. A study of human tissue aminopeptidase components.Arch Biochem Biophys1965; 111: 335–44.
73.
GoldbargJ.A., RutenburgA.M.. The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases.Cancer1958; 11: 283–91.
74.
TamuraY., NiinobeM., ArimaT.. Aminopeptidases and arylamidases in normal and cancer tissues in humans.Cancer Res1975; 35: 1030–4.
75.
WilkinsonJ.H.. The principles and practice of diagnostic enzymology.Moscow: Medicine, 1981; 406.
76.
SulowiczW., ZisiewiczJ., CichockiT., MoszezynskiP.. Leucine aminopeptidase of neutrophiles and lymphocytes in patients with cancer.Folia haematologica1986; 112: 397–403.
77.
Hopsu-HavuV.K., GlennerG.G.. A new dipeptide naphthylamidase hydrolyzing glycylprolyl-β-naphty-lamide.Histochemie1966; 7: 197–201.
78.
Hopsu-HavuV.K., RintolaP., GlennerG.G.. A hog kidney aminopeptidase liberating N-terminal dipeptides. Partial purification and characteristics.Acta Chim Scand1968; 21: 299–308.
79.
KojimaJ., KanataniM., TohjohF., NakamuraN.. Serum glycylproline dipeptidyl aminopeptidase activity in human hepatic cancer.Clin Chim Acta1979; 93: 181–7.
80.
KojimaJ., KanataniM., NakamuraN., KashiwagiT., TohiohF., AkiamaM.. Serum and liver glycylproline dipeptidyl aminopeptidase activity in rats with experimental hepatic cancer.Clin Chim Acta1980; 107: 105–10.
81.
KojimaJ., UenoY., KasugaiH., OkudaS., HitoshiA.. Glycylproline dipeptidyl aminopeptidase and γ-glu-tamyl transpeptidase in human hepatic cancer and embryonal tissues.Clin Chim Acta1987; 167: 285–91.
WeinbergW.C., BerkwitsL., IannacconeP.. The clonal nature of carcinogen-induced altered foci of γ-glu-tamyl transpeptidase expression in rat liver.Carcinogenesis1987; 8: 565–70.
85.
SulakheS.J., LautW.W.. A characterization of γ-glu-tamyltranspeptidase in normal, perinatal, premalig-nant and malignant rat liver.Int J Biochem1987; 19: 23–32.
86.
HaniganH.M., PitotH.C.. Isolation of gamma-glutamyl transpeptidase positive hepatocytes during early stages of hepatocarcinogenesis in the rat.Carcinogenesis1982; 3: 1349–54.
87.
HubermanE., MontesanoR., DrevonC.. Gamma-glutamyl transpeptidase and malignant transformation of cultured liver cells.Cancer Res1979; 39: 269–72.
88.
FarberE.. The sequential analysis of liver cancer induction.Biochim Biophys Acta1980; 605: 149–66.
89.
HaniganM.H., PitotH.C.. Gamma-glutamyl transpeptidase – its role in hepatocarcinogenesis.Carcinogenesis1985; 6: 165–72.
90.
GorkinV.Z.. Aminooxidase and its significance for medicine (in Russian)Moscow: Medicine, 1981; 209.
HiramatsuY., EguchiK., SekibaK.. Alterations in polyamine levels in amniotic fluid, plasma and urine during normal pregnancy.Acta Med Okayama1985; 39: 339–45.
97.
RussellD.H., GilesH.R., ChristianC.D., CampbellJ.Z.. Polyamines in amniotic fluids, plasma and urine for a normal pregnancy.Amer J Obstet Gynecol1978, 132: 649–52.
98.
ScalabrinoG., FerioliE.. Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: a useful new index of degree of malignancy. In: NieburgsH.E., HolznerJ.H., ValliV.E., eds. Tumor markers in cancer control.New York: Liss, 1985; 11–6.
99.
RussellD.H., McVickerT.A.. Polyamines in the developing rats and in supportive tissues.Biochim Biophys Acta1972; 259: 247–58.
100.
KubotaS., YoshimotoM., YamasakiZ.. Urinary polyamines as a tumor markers. In: NieburgsH.E., HolznerJ.H., ValliV.E., eds. Tumor markers in cancer control.New York: Liss, 1985; 189–92.
101.
NotoT., HashimotoH., NakaoJ., KamimuraH., NakajimaT.. Spontaneous release of γ-aminobutiric acid formed from putrescine and its enhanced Ca2+-dependent release by high K+ stimulation in the brain of freely moving rats.J Neurichem1986; 46: 1877–80.
102.
FogelW.A., GABA and polyamine metabolism in peripheral tissues. In: ErdoS.L., BoweryN.G., eds. GABAergic mechanisms in the mammalian.New York: Raven Press, 1986; 35–56.
103.
DelRioR.M., CaballeroA.L.. Presence of γ-aminobu-tiric acid in rat ovary. J.Neurochem1980; 34: 1584–6.
104.
ErdoS.L., LasloA., KissB., ZsolnaiB.. Presence of gamma-aminoabutiric acid and its specific receptor binding sites in the human term placenta.Ginecol Obstet Invest1985; 20: 199–203.
105.
FercanyJ.W., SmithL.A., SeifertW.E., CaprioliR.M., EnnaS.J.. Measurement of gamma-aminobutiric acid (GABA) in blood.Life Sci1978; 22: 2121–8.
106.
SedilerN., EichentopfB.. 4-Aminobutirate in mammalian putrescine metabolism.Biochem J1975; 152: 21–10.
107.
SchuttA., MeghjiS., HarveyW.. Stimulation of human fibroblast collagen synthesis in vitro by γ-aminobutiric acid.Biochem Pharmacol1987; 36: 1333–5.
108.
FogelW.A., BieganskiT., SchayerR.W., MaslinskiC.. Involvement of diamine oxidase in catabolism of 14C-putrescine in mice in vitro: a special reference to the formation of γ-aminoabutiric acid.Agents Actions1981; 11: 679–84.
109.
WilsonW.E., HillR.J., KoepperR.E.. The metabolism of γ-aminobutiric acid 4-14C by intact rats.J Biol Chem1959; 234: 347–9.
110.
GaugasJ.M., CurzenP.. Polyamine interaction with pregnancy serum in suppression of lymphocyte transformation.Lancet1978; 1: 18–20.
111.
SobueK., NakajimaT.. Metabolism of putrescine in neuroblastoma and glioma cells during culture.J Biochem1977; 82: 1121–6.
112.
ChenK.Y., LiuAY-C. Differences in polyamine metabolism of the undifferentiated neuroblastoma cells.FEBS Lett1981; 134: 71–4.
113.
TatarinovYuS, PetruninD.D.. Fertility-associzated protein factor.Obstetrics and Gynecology (in Russian)1978; 8: 10–3.
114.
TatarinovYuS, OlefirenkoG.A., PetruninD.D.. Alpha-2-microglobulin of fertility.Advances of modern biology (in Russian)1985; 100: 465–72.